Ç. Gerçel-Taylor
Molecular Biology · 2008
A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 14 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 16 citations into it; #3,068 of 17,773 by trust here, #4,474 by citations
- Cancer Research — 11 citations into it; #217 of 1,780 by trust here, #511 by citations
Whom Ç. Gerçel-Taylor trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Ç. Gerçel-Taylor overall
- Suresh Mathivanan
- Hamish W. King
- Richard J. Simpson
- Raghu Kalluri
- S. Roychowdhury
- I. Colao
- Asfar S. Azmi
- H. Ji
- Christoph Kahlert
Papers from Ç. Gerçel-Taylor's perspective
Ordered by how strongly the researchers Ç. Gerçel-Taylor trusts endorse each paper. Same corpus, a different order for every researcher.
- How microRNAs control cell division, differentiation and death. (Current Opinion in Genetics and Development)
- microRNAs exhibit high frequency genomic alterations in human cancer. (Proceedings of the National Academy of Sciences of the United States of America)
- MicroRNA expression profiles classify human cancers (Nature)
- MicroRNA signatures in human cancers (Nature Reviews. Cancer)
- Oncomirs — microRNAs with a role in cancer (Nature Reviews. Cancer)
- Malignant effusions and immunogenic tumour-derived exosomes. (The Lancet)
- MicroRNA signatures in human ovarian cancer. (Cancer Research)
- MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. (Cancer Research)
- Worldwide burden of gynaecological cancer: the size of the problem. (Best Practice & Research: Clinical Obstetrics & Gynaecology)
- MicroRNA-cancer connection: the beginning of a new tale. (Cancer Research)
Their papers
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. (2008) — 2,343 citations
- Exosomal microRNA: a diagnostic marker for lung cancer. (2008) — 1,278 citations